S-2-Propenyl-L-Cysteine.

S-1-propenylcysteine forms during the long ageing of garlic and is one of the stable water-soluble sulfur markers used to characterise aged garlic extract, so the isolated compound and the whole extract carry the same active chemistry, one concentrated and one in its natural matrix.

The compound is a cysteine derivative handled through the sulfur amino acid pool, so cysteine availability sits upstream of its metabolism and of the sulfane sulfur pool it contributes to.

Both are cysteine derivatives feeding the same thiol and sulfane sulfur pool, the route through which garlic sulfur compounds signal via hydrogen sulfide chemistry.

EPA lowers thromboxane A2 production at cyclooxygenase and garlic sulfur compounds damp platelet activation through calcium signalling, so platelet reactivity is reduced by two routes at once.

Garlic bulbs store gamma-glutamyl-S-1-propenylcysteine, the peptide precursor that is cleaved to S-2-propenyl-L-cysteine during extended ageing or processing. Fresh garlic therefore carries the precursor rather than much of the free amino acid itself. The relationship is a source relationship, not an additive effect on any measured outcome.

Both compounds feed the body's sulfur amino acid pool, methionine through transmethylation and transsulfuration, the cysteine conjugate through cysteine handling. They meet at cysteine rather than at a single enzyme. This is a shared-pathway description and not evidence that the pair changes any clinical measure.

Cystathionine beta-synthase and cystathionine gamma-lyase, the two enzymes that carry sulfur from homocysteine through to cysteine, are both pyridoxal-5-phosphate dependent. Cysteine-family compounds enter downstream of that junction. Adequate B6 status is what keeps the transsulfuration limb moving.

Sulfite oxidase, the molybdenum cofactor enzyme, converts sulfite to sulfate at the end of sulfur amino acid catabolism. Any sulfur-bearing amino acid derivative eventually loads that step. Molybdenum status is the limiting factor for the terminal oxidation, not for absorption of the garlic compound.

Methionine synthase uses cobalamin to remethylate homocysteine back to methionine, the branch that competes with transsulfuration for the same homocysteine pool. Sulfur amino acid derivatives sit downstream of that branch point. B12 status therefore shapes how much sulfur is pushed toward cysteine.

5-methyltetrahydrofolate supplies the methyl group that methionine synthase transfers to homocysteine. That reaction sets how much homocysteine remains for the transsulfuration limb where cysteine-type compounds circulate. The link is metabolic accounting, not a demonstrated combined effect.

Glutathione synthesis is limited by cysteine availability, and cysteine conjugates such as this one sit in the same chemical family. Whether the compound releases usable cysteine in people has not been established in the sources available here. Read the pairing as mechanistic rather than clinical.

Taurine is formed from cysteine by cysteine dioxygenase and decarboxylation, so it shares an upstream pool with cysteine derivatives. Supplying one does not automatically raise the other. The pairing describes a common route, nothing measured.

Selenium travels through several of the same enzymes that handle sulfur amino acids, since selenocysteine and cysteine are chemical analogues. Formulators pair garlic sulfur compounds with selenium for that reason. No combination measurement in people is available here.

Ascorbate keeps thiol groups in their reduced state in solution, which is the usual rationale for pairing it with sulfur-containing ingredients. The interaction is chemical rather than a clinical finding. Nothing here shows the pair changes an outcome in people.

Cysteine-type thiols coordinate zinc readily, which is why zinc-cysteine complexes exist as deliberate formulation choices. In a mixed capsule that binding can change how each component dissolves. This is a formulation consideration, not an absorption claim in either direction.

Garlic-derived sulfur compounds and quercetin appear together in circulatory-support blends because both are plant constituents with long histories of combined use. The pairing is a formulation convention. No combination study grounds it here.